FDA statement on approval of OTC Primatene Mist to treat mild asthma - FDA Press Releases

FDA approves new version of OTC Primatene Mist inhaler to treat mild, intermittent asthma for people who have been diagnosed with asthma by their physician

from FDA Press Releases RSS Feed http://bit.ly/2DHOgga
via IFTTT